drugset / Trial / NCT00867399

A Safety and Tolerability Study of ABT-126 in Elderly

NCT00867399

Phase 1 Completed 30 enrolled Abbott
RandomizedSingle-groupDouble-blindTreatment

Summary

The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.

Timeline

Start
2009-03
Primary completion
2009-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator ABT-126 Small molecule 20 mg
Comparator ABT-126 Small molecule 30 mg
Comparator ABT-126 Small molecule 45 mg

Indications